BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2022
View Archived Issues
Blocking UBE2N evades oncogenic immune signaling in AML
Read More
TYK2 inhibitors described by Ennovabio (Zhejiang) Pharmaceuticals, Shanghai Ennova Biopharmaceutical
Read More
New Bruton tyrosine kinase inhibitors identified at Beijing Innocare Medical Technology
Read More
Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers
Read More
Medshine Discovery identifies new cyclin/CDK inhibitors
Read More
RIG1 activation confers protection against SARS-CoV-2 infection in mice
Read More
Study reveals dopamine as a sleep disorders target
Read More
Targeting PTP1B enhances T cell-mediated antitumor immunity
Read More
FDA grants orphan drug designation to HT-KIT for mastocytosis
Read More
Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models
Read More
Del-1 potentiates BCI efficacy by blockade of tumor-infiltrating neutrophils
Read More
Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies
Read More